☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Targeted Engineered Toxin Bodies
Takeda signs a Co-Development Agreement with Molecular Templates for CD38-Targeted Engineered Toxin Bodies(ETBs) for Multiple Myel...
September 20, 2018
Load more...
Back to Home